Intra-cranial efficacy of brigatinib in an ALK-positive non-small cell lung cancer patient presenting leptomeningeal carcinomatosis. [electronic resource]
Producer: 20200305Description: 1-3 p. digitalISSN:- 1872-8332
- Adult
- Anaplastic Lymphoma Kinase -- antagonists & inhibitors
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Brain -- drug effects
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Crizotinib -- therapeutic use
- Drug Resistance, Neoplasm
- Female
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Meningeal Carcinomatosis -- drug therapy
- Middle Aged
- Organophosphorus Compounds -- therapeutic use
- Pyrimidines -- therapeutic use
- Survival Analysis
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.